Swedbank Reports Third-Quarter Profit of 8.2 Billion
Swedbank said third-quarter profit rose to 8.2 billion and return on equity reached 15.6%. Net interest and commission income increased, while net gains and losses decreased.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
30 results loaded, newest first. More results are available. The latest changes are still being indexed. Try again shortly for updated results.
Sandvik Reports 25% Organic Revenue Growth in Third Quarter
Sandvik reported Q3 2026 order intake growth of 20% and organic revenue growth of 25%. Adjusted EBITDA margin was 22.5%, and free operating cash flow reached a record-high 7.2 billion SEK.
Lam Research Reports September-Quarter Records, Sees 2027 WFE Above $200 Billion
Lam Research reported record revenue and profitability for the September 2026 quarter, with operating margin topping 40% for the first time. The company’s preliminary 2027 wafer fabrication equipment outlook is for spending above $200 billion, with growth led by DRAM.
Danaher Raises 2026 EPS Guidance After Third-Quarter Results
Danaher reported third-quarter core revenue growth of 5.5%, excluding respiratory revenue, and a nearly 30% adjusted operating profit margin. It raised full-year adjusted diluted EPS guidance to $8.57–$8.62 and expects fourth-quarter core revenue growth, excluding respiratory revenue, of 4%–5%.
Capital One Reports Q3 2026 Earnings of $3.5 Billion
Capital One reported third-quarter earnings of $3.5 billion, or $5.61 per diluted share; adjusted earnings per share were $6.69. Loans rose 1% and deposits fell 1% from the prior quarter.
Ally Financial Reports Q3 Adjusted EPS of $1.34, Up 16%
Ally Financial reported third-quarter adjusted EPS of $1.34, up 16% year over year, and adjusted net revenue of $2.3 billion, up 9%. CET1 was 10.2%, up 10 basis points year over year.
Halliburton Reports Q3 Revenue of $5.7 Billion, Sets 2027 Outlook
Halliburton reported third-quarter 2026 revenue of $5.7 billion and an adjusted operating margin of 12.8%. The company said it expects mid-single-digit revenue growth and operating margins of about 15% in 2027, an improvement of about 200 basis points.
Zions Bancorp Reports Q3 2026 Earnings Per Share of $1.78
Zions Bancorp reported third-quarter net earnings of $262 million, up 20% year over year, and earnings per share of $1.78 versus $1.48 a year earlier. Net interest margin was 3.23%, down 5 basis points year over year.
PNC Reports Q3 Net Income of $2.1 Billion, EPS of $5.09
PNC Financial Services Group reported third-quarter net income of $2.1 billion, or $5.09 per diluted share, and return on tangible common equity above 18%. It forecast Q4 average loan growth of 2.5% and net interest income growth of 4%.
Equity Bancshares Reports Q3 Net Income of $26.8 Million
Equity Bancshares reported third-quarter net income of $26.8 million, or $1.29 per diluted share, and core earnings of $29 million. Legacy-market loans grew at an annualized rate of nearly 12%, and the company said total loan balances increased for the first time since its acquisition.
EOG Resources Reports Record Q2 2026 Results, $5.07 Adjusted EPS
EOG Resources reported record second-quarter 2026 financial performance, including adjusted EPS of $5.07 and free cash flow of $2.8 billion. The company returned $1.8 billion to shareholders and reported oil production growth of 5% and total production growth of 14%.
Morgan Stanley Reports Q3 Revenue of $20.3 Billion, EPS of $3.03
Morgan Stanley reported third-quarter revenue of $20.3 billion and earnings per share of $3.03, with return on tangible equity of 22.6%. Wealth Management revenue exceeded $9 billion, while Institutional Securities revenue rose 18% year over year to $10 billion.
BlackRock Reports Q3 Revenue Growth of 19% to $7.8 Billion
BlackRock reported third-quarter 2026 revenue of $7.8 billion, up 19% year over year, and $205 billion in net inflows. Adjusted operating margin reached 47.8%, up 320 basis points year over year.
Arcturus Completes ARCT810 Phase 2 Enrollment and Dosing
Arcturus Therapeutics said enrollment is complete and all participants have finished study-drug dosing in its ARCT810 Phase 2 trial for OTC deficiency. The company expects to report clinical data in Q3 2026.
Transcript: Vistra Q2 2026 Earnings Conference Call
Vistra (NYSE: VST ) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Vistra Corp reported strong
Trulieve Reports Q2 Revenue of $271 Million, 60% Gross Margin
Trulieve reported second-quarter 2026 revenue of $271 million, a 60% gross margin and adjusted EBITDA of $98 million. The company said third-quarter revenue is expected to be comparable to the second quarter.
Trulieve Reports Q2 Revenue of $271 Million, Adjusted EBITDA of $98 Million
Trulieve reported second-quarter 2026 revenue of $271 million, a 60% gross margin and adjusted EBITDA of $98 million. Management said Q3 revenue is expected to be comparable to the medical-only business’s Q2 revenue of $222 million.
TKO Raises 2026 Guidance After Second-Quarter Revenue Rises 18%
TKO Group Holdings reported Q2 2026 revenue of $1.547 billion, up 18% year over year, and adjusted EBITDA of $650 million, up 23%. It raised full-year 2026 revenue guidance to $5.775 billion-$5.825 billion and adjusted EBITDA guidance to $2.275 billion-$2.305 billion.
Doximity Reports Q1 Revenue of $157 Million, Raises Full-Year Guidance
Doximity reported fiscal Q1 2027 revenue of $157 million, up 7% year over year, and adjusted EBITDA of $75 million at a 48% margin. The company raised full-year revenue guidance, representing 5% growth.
Bridger Aerospace Reports Q2 Revenue of $30.5 Million, Reaffirms 2026 Guidance
Bridger Aerospace reported second-quarter revenue of $30.5 million, flat year over year, and a net loss of $0.5 million. It reiterated its 2026 guidance.
Oncology Institute Raises 2026 Revenue and Gross Profit Guidance
Oncology Institute reported Q2 revenue of approximately $161 million, up 35% year over year, and positive adjusted EBITDA. It raised full-year revenue guidance to $650–670 million and gross profit guidance to $105–110 million.
QuidelOrtho Reports Q2 Revenue Growth, Raises EBITDA and Cuts 2026 Guidance
QuidelOrtho reported Q2 2026 revenue growth of 2% and adjusted EBITDA of $129 million, up 21%. It lowered 2026 revenue guidance to $2.52 billion-$2.60 billion amid China-related challenges and withdrew free cash flow guidance.
Onto Innovation Q2 2026 Earnings Call: Complete Transcript
On Thursday, Onto Innovation (NYSE: ONTO ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call at Summary Onto Innovation repo
Blend Labs Q2 2026 Earnings Call: Complete Transcript
On Thursday, Blend Labs (NYSE: BLND ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Blend Labs
Transcript: Shoulder Innovations Q2 2026 Earnings Conference Call
On Thursday, Shoulder Innovations (NYSE: SI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Shoulder Innovations reported a 56% ye
ResMed Q4 2026 Earnings Call Transcript
ResMed (NYSE: RMD ) reported fourth-quarter financial results on Thursday. The transcript from the company's fourth-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary ResMed Inc reported a strong
Coeur Mining Q2 2026 Earnings Call: Complete Transcript
Coeur Mining (NYSE: CDE ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Coeur Mining reported record financial results for the se
Flu season is already here. Here’s what to know about this year’s flu shots.
This year’s flu season has arrived about seven weeks earlier than in 2025 or 2024.
Radian Group Reports Q2 2026 Results: Full Earnings Call Transcript
Radian Group (NYSE: RDN ) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Radian Group reported a 93% increase in total revenues ye
Genworth Financial Q2 2026 Earnings Call: Complete Transcript
Genworth Financial (NYSE: GNW ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Genworth Financial reported a net income of $47 mi